Jubilant Pharma, Singapore issues Unsecured High Yield Bonds
Jubilant Life Sciences announced that its wholly owned subsidiary, Jubilant Pharma, Singapore has successfully completed on 06 October 2016, a debt issue of its rates unsecured high yield bonds (Notes) bearing interest of 4.875% per annum. The Notes were issued at par in a principal amount of USD 300 million and will mature in October 2021. The Notes will be listed on Singapore Exchange Securities Trading.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
